CAS: 1029712-80-8 - Capmatinib

Fórmula: C₂₃H₁₇FN₆O

InChI: InChI=1S/C23H17FN6O/c1-25-22(31)18-6-5-16(11-19(18)24)21-13-28-23-27-12-17(30(23)29-21)10-14-4-7-20-15(9-14)3-2-8-26-20/h2-9,11-13H,10H2,1H3,(H,25,31)

Chave InChI: InChIKey=LIOLIMKSCNQPLV-UHFFFAOYSA-N

SMILES: O=C(NC)C=1C=CC(=CC1F)C2=NN3C(N=C2)=NC=C3CC4=CC=C5N=CC=CC5=C4

Sinónimos:

• 2-Fluoro-N-methyl-4-[7-(6-quinolinylmethyl)imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide
• 2-Fluoro-N-methyl-4-[7-[(quinolin-6-yl)methyl]imidazo[1,2-b]-[1,2,4]triazin-2-yl]benzamide
• Benzamide, 2-fluoro-N-methyl-4-[7-(6-quinolinylmethyl)imidazo[1,2-b][1,2,4]triazin-2-yl]-
• Inc 280
• Incb 28060
• Incb28060
• NC280 BenzaMide,2-fluoro-N-Methyl-4-[7-(6-quinolinylMethyl)iMidazo[1,2-b][1,2,4]triazin-2-yl]-
• Nvp-Inc 280Nx
• Tabrecta

2-Fluoro-N-methyl-4-[7-(6-quinolinylmethyl)imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide

CAS: 1029712-80-8

• Fórmula: C₂₃H₁₇FN₆O
• Pureza: ≥98%
• Cor e Forma: Solid
• Peso molecular: 412.4191

Capmatinib

CAS: 1029712-80-8

Capmatinib (INCB28060) is an orally bioavailable inhibitor of the proto-oncogene c-Met (HGFR)with potential antineoplastic activity.

• Fórmula: C₂₃H₁₇FN₆O
• Pureza: 99.76%
• Cor e Forma: Solid
• Peso molecular: 412.42

Capmatinib

CAS: 1029712-80-8

Selective c-Met kinase inhibitor

• Fórmula: C₂₃H₁₇FN₆O
• Pureza: Min. 95 Area-%
• Cor e Forma: Slightly Yellow Powder
• Peso molecular: 412.42 g/mol

2-Fluoro-N-methyl-4-(7-(quinolin-6-ylmethyl)imidazo[1,2-b][1,2,4]triazin-2-yl)benzamide

CAS: 1029712-80-8

• Fórmula: C₂₃H₁₇FN₆O
• Cor e Forma: White to Off-White Solid
• Peso molecular: 412.43